Original Research
Apr 29
Claudio Montalto, Jacopo A. Oreglia et al.
In patients undergoing TAVI and complex/high-risk PCI, a concomitant strategy was associated with a higher rate of adverse events compared to a staged approach.
Debate
Apr 28
Philippe Garot, Michael A. Borger, et al.
The content discusses the debate around lowering the age threshold for transcatheter aortic valve implantation (TAVI) below 65 years, with pros and cons presented.
Editorial
Apr 25
Michael Joner, Darren Mylotte
This study reports significantly lower echocardiography-derived gradients in self-expanding transcatheter aortic valves compared to balloon-expandable valves, while invasively measured gradients were similar, highlighting the pressure recovery phenomenon.
free
Expert Consensus
Apr 24
Simone Fezzi, Patrick W. Serruys, et al.
This consensus document from the Drug Coated Balloon Academic Research Consortium covers a wide range of cardiology interventions, including coronary, valvular, heart failure, and peripheral procedures, as well as treatments for hypertension and stroke prevention.
Original Research
Apr 24
Mark M.P. van den Dorpel, Nicolas M. van Mieghem, et al.
This study found that only invasively measured, but not echocardiography-derived, transvalvular mean gradients correlated with mortality after TAVI.
State-of-the-Art
Apr 22
Agam Bansal, Samir R. Kapadia, et al.
This article reviews the potential complications associated with transcatheter valve interventions, including TAVI, TMVR, and TMVR, and provides insights into their prevention, diagnosis, and management.
free
NEW ISSUE
Apr 21
Debating the TAVI age limit; a State-of-the-Art on the management of complications after valvular interventions; invasive versus echocardiography-derived gradients after TAVI; complex PCI and TAVI; mapping interventional cardiology in Europe; bioprosthetic failure ten years after TAV-in-SAV
Meet Cory, your AI Assistant!
Learn more
Enhance your reading experience and get deeper insights on complex topics.
FLASHLIGHT
Apr 21
Julius Jelisejevas, David A. Wood et al.
This case highlights the challenges in the lifelong management of aortic valve disease, emphasizing the importance of optimizing aortic valve implantation during the index procedure to enhance redo options.
Editorial
Apr 18
Sunil V. Rao, Louai Razzouk
The study found that the site of radial artery access (cTRA or dTRA) does not impact radial artery occlusion, and adequate systemic anticoagulation is essential to reduce radial artery occlusion, regardless of access site.
free
Original Research
Apr 16
Thomas Stiermaier, Ingo Eitel
The RAPID trial found that while distal transradial access did not reduce radial artery occlusion compared to conventional access, procedural anticoagulation significantly reduced the incidence of occlusion without increasing bleeding risk.
Research Correspondence
Apr 15
Alexander M. Griffioen, Robert Jan M. van Geuns, et al.
This study demonstrates the safety and feasibility of using a completely percutaneous VA-ECMO approach with local anesthesia during high-risk PCI, with excellent outcomes in terms of successful revascularization and low rates of adverse events.
Editorial
Apr 14
Manel Sabaté
The content discusses the evolution of treatment options for in-stent restenosis, with drug-coated balloons demonstrating efficacy and potential for treating de novo lesions, while bioresorbable scaffolds have shown mixed results.
free
Flashlight
Apr 11
Jason Leo Walsh, Giovanni Luigi De Maria, et al.
This study explores the feasibility of using stent retriever-assisted thrombectomy for thrombus modification in ST-segment elevation myocardial infarction with a large thrombus burden, an approach that has shown efficacy in stroke intervention.
Original Research
Apr 10
Richard Tanner, Samin K. Sharma, et al.
Patients with multilayer drug-eluting stent in-stent restenosis treated with intravascular brachytherapy had a lower risk of major adverse cardiac events at 3-year follow-up compared to those treated with a non-IVBT strategy.
Trending articles
Swimming against the tide: insights from the ORBITA trial
Management of complications after valvular interventions
Mechanical circulatory support for complex, high-risk percutaneous coronary intervention
Optical coherence tomography to guide percutaneous coronary intervention
Cerebral embolisation during transcatheter edge-to-edge repair of the mitral valve with the MitraClip system: a prospective, observational study
Clinical outcomes of calcified nodules detected by optical coherence tomography: a sub-analysis of the CLIMA study
Dynamic Coronary Roadmap versus standard angiography for percutaneous coronary intervention: the randomised, multicentre DCR4Contrast trial
Outcomes of complex, high-risk percutaneous coronary intervention in patients with severe aortic stenosis: the ASCoP registry
Durability of transcatheter aortic valve implantation
Periprocedural elevated myocardial biomarkers and clinical outcomes following elective percutaneous coronary intervention: a comprehensive dose-response meta-analysis of 44,972 patients from 24 prospective studies
10.4244/EIJV13I12A217 • Dec 8, 2017
Al-Lamee R and Francis D
free
State-of-the-Art
10.4244/EIJ-D-24-00066 • Apr 21, 2025
Bansal A et al
free
State-of-the-Art
10.4244/EIJ-D-24-00386 • Feb 3, 2025
Ferro E et al
free
State-of-the-Art
10.4244/EIJ-D-23-00912 • Oct 7, 2024
Almajid F et al
free
Clinical Research
10.4244/EIJ-D-21-00646 • Jun 3, 2022
Braemswig T et al
free
Clinical research
10.4244/EIJ-D-19-01120 • Aug 28, 2020
Prati F et al
free
Original Research
10.4244/EIJ-D-23-00460 • Feb 5, 2024
Hennessey B et al
open access
Original Research
10.4244/EIJ-D-24-00933 • Apr 21, 2025
Montalto C et al
State-of-the-Art
10.4244/EIJ-D-23-01050 • Jul 15, 2024
Ternacle J et al
free
Clinical research
10.4244/EIJ-D-19-00737 • Mar 20, 2020
Li Y et al
free
